Identification of protein biomarkers for prediction of response to platinum‐based treatment regimens in patients with non‐small cell lung cancer von Böttger, Franziska, Radonic, Teodora, Bahce, Idris, Monkhorst, Kim, Piersma, Sander R., Pham, Thang V., Dingemans, Anne‐Marie C., Hillen, Lisa M., Santarpia, Mariacarmela, Giovannetti, Elisa, Smit, Egbert F., Burgers, Sjaak A., Jimenez, Connie R.

Volltext

Characteristics of patients with advanced cancer preferring not to know prognosis: a multicenter survey study von van der Velden, Naomi C. A, van Laarhoven, Hanneke W. M, Burgers, Sjaak A, Hendriks, Lizza E. L, de Vos, Filip Y. F. L, Dingemans, Anne-Marie C, Jansen, Joost, van Haarst, Jan-Maarten W, Dits, Joyce, Smets, Ellen MA, Henselmans, Inge

Volltext

Randomized Phase II and Pharmacogenetic Study of Pemetrexed Compared With Pemetrexed Plus Carboplatin in Pretreated Patients With Advanced Non–Small-Cell Lung Cancer von SMIT, Egbert F, BURGERS, Sjaak A, GROEN, Harry J. M, BIESMA, Bonne, SMIT, Hans J. M, EPPINGA, Pier, DINGEMANS, Anne-Marie C, JOERGER, Markus, SCHELLENS, Jan H, VINCENT, Andrew, VAN ZANDWIJK, Nico

Volltext

Germline Polymorphisms in Patients With Advanced Nonsmall Cell Lung Cancer Receiving First-Line Platinum-Gemcitabine Chemotherapy: A Prospective Clinical Study von JOERGER, Markus, BURGERS, Sjaak. A, BEIJNEN, Jos H, SCHELLENS, Jan H. M, BAAS, Paul, SMIT, Egbert F, HAITJEMA, Tjeerd J, BARD, Martin P. L, DOODEMAN, Valerie D, SMITS, Paul H. M, VINCENT, Andrew, HUITEMA, Alwin D. R

Volltext

Proteomic Analysis of Exosomes Isolated from Human Malignant Pleural Effusions von Bard, Martin P, Hegmans, Joost P, Hemmes, Annabrita, Luider, Theo M, Willemsen, Rob, Severijnen, Lies-Anne A, van Meerbeeck, Jan P, Burgers, Sjaak A, Hoogsteden, Henk C, Lambrecht, Bart N

Volltext

Proteomic Analysis of Exosomes Secreted by Human Mesothelioma Cells von Hegmans, Joost P.J.J., Bard, Martin P.L., Hemmes, Annabrita, Luider, Theo M., Kleijmeer, Monique J., Prins, Jan-Bas, Zitvogel, Laurence, Burgers, Sjaak A., Hoogsteden, Henk C., Lambrecht, Bart N.

Volltext

Modeling strategies to analyse longitudinal biomarker data: An illustration on predicting immunotherapy non-response in non-small cell lung cancer von van Delft, Frederik A., Schuurbiers, Milou, Muller, Mirte, Burgers, Sjaak A., van Rossum, Huub H., IJzerman, Maarten J., Koffijberg, Hendrik, van den Heuvel, Michel M.

Volltext

Crizotinib-induced fatal fulminant liver failure von van Geel, Robin M.J.M, Hendrikx, Jeroen J.M.A, Vahl, Jelmer E, van Leerdam, Monique E, van den Broek, Daan, Huitema, Alwin D.R, Beijnen, Jos H, Schellens, Jan H.M, Burgers, Sjaak A

Volltext

Optimal Therapy of Advanced Stage Mesothelioma von Disselhorst, Maria M. J., Burgers, Sjaak J. A., Baas, Paul

Volltext

Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy von Leijen, Suzanne, Burgers, Sjaak A., Baas, Paul, Pluim, Dick, Tibben, Matthijs, van Werkhoven, Erik, Alessio, Enzo, Sava, Gianni, Beijnen, Jos H., Schellens, Jan H. M.

Volltext

Concentrations of Erlotinib in Tumor Tissue and Plasma in Non–Small-Cell Lung Cancer Patients After Neoadjuvant Therapy von Lankheet, Nienke A.G, Schaake, Eva E, Burgers, Sjaak A, van Pel, Renée, Beijnen, Jos H, Huitema, Alwin D.R, Klomp, Houke

Volltext

Prolonged sampling of spontaneous sputum improves sensitivity of hypermethylation analysis for lung cancer von Hubers, A Jasmijn, Heideman, Daniëlle A M, Herder, Gerarda J M, Burgers, Sjaak A, Sterk, Peter J, Kunst, Peter W, Smit, Henk J, Postmus, Pieter E, Witte, Birgit I, Duin, Sylvia, Snijders, Peter J F, Smit, Egbert F, Thunnissen, Erik

Volltext

Prognostic Value of Nivolumab Clearance in Non-Small Cell Lung Cancer Patients for Survival Early in Treatment von Otten, Leila S., Piet, Berber, van den Haak, Demy, Schouten, Robert D., Schuurbiers, Milou, Badrising, Sushil K., Boerrigter, Emmy, Burgers, Sjaak A., ter Heine, Rob, van den Heuvel, Michel M.

Volltext

Transesophageal Endoscopic Ultrasound with Fine Needle Aspiration in the Preoperative Staging of Malignant Pleural Mesothelioma von TOURNOY, Kurt G, BURGERS, Sjaak A, ANNEMA, Jouke T, VERMASSEN, Frank, PRAET, Marleen, SMITS, Marianne, KLOMP, Houke M, VAN MEERBEECK, Jan P, BAAS, Paul

Volltext

Comparing modeling strategies combining changes in multiple serum tumor biomarkers for early prediction of immunotherapy non-response in non-small cell lung cancer von van Delft, Frederik A, Schuurbiers, Milou M F, Muller, Mirte, Burgers, Sjaak A, van Rossum, Huub H, IJzerman, Maarten J, van den Heuvel, Michel M, Koffijberg, Hendrik

Volltext

Prevalence and Predictors of Physician-Patient Discordance in Prognostic Perceptions in Advanced Cancer von van der Velden, Naomi Cornelia Anna, Han, Paul K J, van Laarhoven, Hanneke W M, de Vos, Filip Y F L, Hendriks, Lizza E L, Burgers, Sjaak A, Dingemans, Anne-Marie C, van Haarst, Jan Maarten W, Dits, Joyce, Smets, Ellen M A, Henselmans, Inge

Volltext

A Phase II Study of Sorafenib in Patients with Platinum-Pretreated, Advanced (Stage IIIb or IV) Non―Small Cell Lung Cancer with a KRAS Mutation von DINGEMANS, Anne-Marie C, MELLEMA, Wouter W, GROEN, Harry J. M, WIJK, Atie Van, BURGERS, Sjaak A, KUNST, Peter W. A, THUNNISSEN, Erik, HEIDEMAN, Danielle A. M, SMIT, Egbert F

Volltext

Tumor flare after start of RAF inhibition in KRAS mutated NSCLC: A case report von Mellema, Wouter W, Burgers, Sjaak A, Smit, Egbert. F

Volltext

Local progression after radiofrequency ablation for pulmonary metastases von von Meyenfeldt, Erik M., Prevoo, Warner, Peyrot, David, Fat, Nathalie Lai A, Burgers, Sjaak J. A., Wouters, Michel W., Klomp, Houke M.

Volltext

Timing of metabolic response monitoring during erlotinib treatment in non-small cell lung cancer von van Gool, Matthijs H, Aukema, Tjeerd S, Schaake, Eva E, Rijna, Herman, Valdés Olmos, Renato A, van Pel, Renée, Burgers, Sjaak A, van Tinteren, Harm, Klomp, Houke M

Volltext